Rescue therapy for lamivudine-resistant chronic hepatitis B: When and how?
Open Access
- 26 January 2007
- journal article
- editorial
- Published by Wolters Kluwer Health in Hepatology
- Vol. 45 (2) , 266-268
- https://doi.org/10.1002/hep.21546
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Adding-on versus switching-to adefovir therapy in lamivudine-resistant HBeAg-negative chronic hepatitis BHepatology, 2007
- Chronic hepatitis B: treatment alertLiver International, 2006
- Evolution of multi-drug resistant hepatitis B virus during sequential therapyHepatology, 2006
- Entecavir for Treatment of Lamivudine-Refractory, HBeAg-Positive Chronic Hepatitis BGastroenterology, 2006
- Switching to adefovir monotherapy after emergence of lamivudine‐resistant mutations in patients with liver cirrhosisJournal of Viral Hepatitis, 2006
- Adefovir rapidly suppresses hepatitis B in HBeAg‐negative patients developing genotypic resistance to lamivudine†Hepatology, 2005
- Virologic response and resistance to adefovir in patients with chronic hepatitis BJournal of Hepatology, 2005
- Susceptibility to antivirals of a human HBV strain with mutations conferring resistance to both lamivudine and adefovir†Hepatology, 2005
- Adefovir Dipivoxil Alone or in Combination with Ongoing Lamivudine in Patients with Decompensated Liver Disease and Lamivudine-resistant Hepatitis B VirusJournal of Korean Medical Science, 2005
- Comparison of Adefovir and Tenofovir in the Treatment of Lamivudine–Resistant Hepatitis B Virus InfectionHepatology, 2004